Cefobon SB 1000mg/500mg Injection
Marketer
Nexbon Lifesciences
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Cefobon SB 1000mg/500mg Injection
Cefobon SB 1000mg/500mg Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial growth and proliferation. Administration must be overseen by a physician. Consistent adherence to the prescribed dosage is crucial; prematurely halting treatment may compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions necessitate immediate medical attention. Allergic responses (e.g., rash, itching, edema, respiratory distress) require prompt emergency care. Inform your doctor of all current medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if experiencing dizziness or somnolence. Adequate rest, nutritious food, and hydration are recommended for optimal recovery. Your physician may order tests to monitor the medication's impact.
Uses of Cefobon SB 1000mg/500mg Injection
Combating Bacterial Infections
Major Benefits of Cefobon SB 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cefobon SB 1000mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Cefobon SB 1000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cefobon SB 1000mg/500mg Injection works:
Cefobon SB, a 1000mg/500mg injectable formulation, unites the antibiotic Cefoperazone with the beta-lactamase inhibitor Sulbactam. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam's role is to counter bacterial resistance mechanisms, thereby optimizing Cefoperazone's antibacterial effect.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Cefobon SB 1000mg/500mg Injection treatment can result in adverse effects including facial redness, rapid pulse, queasiness, dehydration, pectoral pain, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable medication Cefobon SB (1000mg/500mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Cefobon SB 1000mg/500mg injection is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
Cefobon SB 1000mg/500mg Injection's effect on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefobon SB 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Cefobon SB 1000mg/500mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Cefobon SB 1000mg/500mg Injection :
Omit a Cefobon SB 1000mg/500mg Injection dose? Seek medical advice immediately.
Facts to Know About Cefobon SB 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently